These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8541268)

  • 21. Increased lenticular aldose reductase activity and high incidence of congenital cataract in the offspring of diabetic rats.
    Simán CM; Naeser P; Eriksson UJ
    Acta Ophthalmol (Copenh); 1993 Oct; 71(5):629-36. PubMed ID: 8109209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new approach against sugar cataract through aldose reductase inhibitors.
    Banditelli S; Boldrini E; Vilardo PG; Cecconi I; Cappiello M; Dal Monte M; Marini I; Del Corso A; Mura U
    Exp Eye Res; 1999 Nov; 69(5):533-8. PubMed ID: 10548473
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunohistochemical localization for aldose reductase in diabetic lenses.
    Akagi Y; Kador PF; Kinoshita JH
    Invest Ophthalmol Vis Sci; 1987 Jan; 28(1):163-7. PubMed ID: 3100473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Control of sorbitol metabolism in renal inner medulla of diabetic rats: regulation by substrate, cosubstrate and products of the aldose reductase reaction.
    Grunewald RW; Weber II; Kinne-Saffran E; Kinne RK
    Biochim Biophys Acta; 1993 Nov; 1225(1):39-47. PubMed ID: 8241288
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Topical aldose reductase inhibitor formulations for effective lens drug delivery in a rat model for sugar cataracts.
    Kador PF; Randazzo J; Babb T; Koushik K; Takamura Y; Zhu W; Blessing K; Kompella UB
    J Ocul Pharmacol Ther; 2007 Apr; 23(2):116-23. PubMed ID: 17444799
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonosmotic diabetic cataracts.
    Malone JI; Lowitt S; Cook WR
    Pediatr Res; 1990 Mar; 27(3):293-6. PubMed ID: 2138728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes of some biochemical parameters of the lens in galactose-treated weaned rats with and without vitamin E therapy.
    Libondi T; Menzione M; Iuliano G; Della Corte M; Latte F; Auricchio G
    Ophthalmic Res; 1985; 17(1):42-8. PubMed ID: 3920597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Positive effects of acarbose in the diabetic rat are not altered by feeding schedule.
    Wright BE; Vasselli JR; Katovich MJ
    Physiol Behav; 1998 Mar; 63(5):867-74. PubMed ID: 9618010
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aldose reductase inhibitors and prevention of galactose cataracts in rats.
    Unakar N; Tsui J; Johnson M
    Invest Ophthalmol Vis Sci; 1989 Jul; 30(7):1623-32. PubMed ID: 2545646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dietary myo-inositol effect on sugar cataractogenesis.
    Beyer-Mears A; Bucci FA; Del Val M; Cruz E
    Pharmacology; 1989; 39(1):59-68. PubMed ID: 2587618
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aldose reductase expression as a risk factor for cataract.
    Snow A; Shieh B; Chang KC; Pal A; Lenhart P; Ammar D; Ruzycki P; Palla S; Reddy GB; Petrash JM
    Chem Biol Interact; 2015 Jun; 234():247-53. PubMed ID: 25541468
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antioxidant potential of fungal metabolite nigerloxin during eye lens abnormalities in galactose-fed rats.
    Suresha BS; Srinivasan K
    Curr Eye Res; 2013 Oct; 38(10):1064-71. PubMed ID: 23767695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cataract development in sand and galactosemic rats fed a natural tomato extract.
    Pollack A; Oren P; Stark AH; Eisner Z; Nyska A; Madar Z
    J Agric Food Chem; 1999 Dec; 47(12):5122-6. PubMed ID: 10606583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aldose reductase in diabetic cataracts.
    Kinoshita JH; Kador P; Catiles M
    JAMA; 1981 Jul; 246(3):257-61. PubMed ID: 6787220
    [No Abstract]   [Full Text] [Related]  

  • 35. A novel high resolution in vivo digital imaging system for the evaluation of experimental cataract in diabetic rats.
    Kametaka S; Kasahara T; Ueo M; Takenaka M; Saito M; Sakamoto K; Nakahara T; Ishii K
    J Pharmacol Sci; 2008 Jan; 106(1):144-51. PubMed ID: 18187926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In utero and milk-mediated effect of aldose reductase inhibitor on galactose cataracts.
    Unakar NJ; Tsui JY; Johnson M; Dang L
    Exp Eye Res; 1991 Nov; 53(5):665-76. PubMed ID: 1743265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beneficial influence of fungal metabolite nigerloxin on eye lens abnormalities in experimental diabetes.
    Suresha BS; Sattur AP; Srinivasan K
    Can J Physiol Pharmacol; 2012 Apr; 90(4):387-94. PubMed ID: 22423974
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sugar cataracts in vitro: implications of oxidative stress and aldose reductase I.
    Chand D; El-Aguizy HK; Richards RD; Varma SD
    Exp Eye Res; 1982 Nov; 35(5):491-7. PubMed ID: 6816623
    [No Abstract]   [Full Text] [Related]  

  • 39. Pyridoxamine inhibits maillard reactions in diabetic rat lenses.
    Padival S; Nagaraj RH
    Ophthalmic Res; 2006; 38(5):294-302. PubMed ID: 16974131
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of novel hydantoin derivatives with aldose reductase inhibiting activity on galactose-induced cataract in rats.
    Kato K; Nakayama K; Ohta M; Murakami N; Murakami K; Mizota M; Miwa I; Okuda J
    Jpn J Pharmacol; 1990 Dec; 54(4):355-64. PubMed ID: 2128352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.